Management Team

Promethera has attracted a leadership team of international experts operating out of R&D and GMP facilities in Mont-Saint-Guibert, Belgium, and Durham, NC, USA.

Executive Management

John Tchelingerian

PhD, President & CEO

Etienne Sokal

MD, PhD, Chief Innovation and Scientific Officer

Frank Hazevoets

Chief Financial Officer & Head Corporate Development

Henrik L. Luessen

PhD, Chief Business Officer

Nancy Veulemans

VP Clinical & Medical Affairs

Decebal Bora

Pharm D., MPH, VP Regulatory Affairs

Mark Johnston

MBA, CCO Promethera Biosciences Group (Belgium) & Managing Director of Promethera Bisociences LLC (USA)

Jef Pinxteren

PhD, VP Operations